Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea A Witkowski, A Prejbisz, E Florczak, J Kądziela, P Śliwiński, P Bieleń, ... Hypertension 58 (4), 559-565, 2011 | 690 | 2011 |
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort TA Williams, JWM Lenders, P Mulatero, J Burrello, M Rottenkolber, ... The lancet Diabetes & endocrinology 5 (9), 689-699, 2017 | 678 | 2017 |
Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19: European Society of Hypertension … R Kreutz, EAEH Algharably, M Azizi, P Dobrowolski, T Guzik, ... Cardiovascular research 116 (10), 1688-1699, 2020 | 452 | 2020 |
Cardiovascular manifestations of phaeochromocytoma A Prejbisz, JWM Lenders, G Eisenhofer, A Januszewicz Journal of hypertension 29 (11), 2049-2060, 2011 | 307 | 2011 |
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine … JWM Lenders, MN Kerstens, L Amar, A Prejbisz, M Robledo, D Taieb, ... Journal of hypertension 38 (8), 1443-1456, 2020 | 269 | 2020 |
Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial T Dekkers, A Prejbisz, LJS Kool, HJMM Groenewoud, M Velema, ... The lancet Diabetes & endocrinology 4 (9), 739-746, 2016 | 265 | 2016 |
Activation of human T cells in hypertension: studies of humanized mice and hypertensive humans HA Itani, WG McMaster Jr, MA Saleh, RR Nazarewicz, TP Mikolajczyk, ... Hypertension 68 (1), 123-132, 2016 | 259 | 2016 |
Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial MD Lobo, PA Sobotka, A Stanton, JR Cockcroft, N Sulke, E Dolan, ... The Lancet 385 (9978), 1634-1641, 2015 | 227 | 2015 |
Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the working group on endocrine hypertension of the european … P Mulatero, S Monticone, J Deinum, L Amar, A Prejbisz, MC Zennaro, ... Journal of hypertension 38 (10), 1919-1928, 2020 | 202 | 2020 |
Primary Aldosteronism Surgery Outcome (PASO) investigators. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures … TA Williams, JWM Lenders, P Mulatero, J Burrello, M Rottenkolber, ... Lancet Diabetes Endocrinol 5 (9), 689-699, 2017 | 186 | 2017 |
Zasady postępowania w nadciśnieniu tętniczym—2019 rok A Tykarski, KJ Filipiak, A Januszewicz, M Litwin, K Narkiewicz, A Prejbisz, ... Nadciśnienie Tętnicze w Praktyce 5 (1), 1-86, 2019 | 171 | 2019 |
Clinical characterization of the pheochromocytoma and paraganglioma susceptibility genes SDHA, TMEM127, MAX, and SDHAF2 for gene-informed prevention B Bausch, F Schiavi, Y Ni, J Welander, A Patocs, J Ngeow, U Wellner, ... JAMA oncology 3 (9), 1204-1212, 2017 | 170 | 2017 |
Clinical characteristics of patients with resistant hypertension: the RESIST-POL study E Florczak, A Prejbisz, E Szwench-Pietrasz, P Śliwiński, P Bieleń, ... Journal of human hypertension 27 (11), 678-685, 2013 | 158 | 2013 |
Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated O-Methylated … G Eisenhofer, A Prejbisz, M Peitzsch, C Pamporaki, J Masjkur, ... Clinical Chemistry 64 (11), 1646-1656, 2018 | 155 | 2018 |
Decreased plasma concentration of a novel anti-inflammatory protein—adiponectin—in hypertensive men with coronary artery disease Z Dzielińska, A Januszewicz, A Więcek, M Demkow, ... Thrombosis research 110 (5-6), 365-369, 2003 | 154 | 2003 |
Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas C Pamporaki, B Hamplova, M Peitzsch, A Prejbisz, F Beuschlein, ... The Journal of Clinical Endocrinology & Metabolism 102 (4), 1122-1132, 2017 | 150 | 2017 |
Extra-adrenal and adrenal pheochromocytomas associated with a germline SDHC mutation M Pęczkowska, A Cascon, A Prejbisz, A Kubaszek, J B Ćwikła, ... Nature clinical practice Endocrinology & metabolism 4 (2), 111-115, 2008 | 144 | 2008 |
PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021 M Banach, P Burchardt, K Chlebus, P Dobrowolski, D Dudek, K Dyrbuś, ... Archives of Medical Science: AMS 17 (6), 1447, 2021 | 143 | 2021 |
Quality of life in primary aldosteronism: a comparative effectiveness study of adrenalectomy and medical treatment M Velema, T Dekkers, A Hermus, H Timmers, J Lenders, H Groenewoud, ... The Journal of Clinical Endocrinology & Metabolism 103 (1), 16-24, 2018 | 125 | 2018 |
Biochemical diagnosis of phaeochromocytoma using plasma‐free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions R Därr, C Pamporaki, M Peitzsch, K Miehle, A Prejbisz, M Peczkowska, ... Clinical endocrinology 80 (4), 478-486, 2014 | 120 | 2014 |